Journal ArticleOPEN ACCESS

Novel Methylcobalamin Nasal Spray versus Intramuscular Injection: A Randomized, Crossover Comparative Bioavailability Study

  • H D
  • V A
  • A M
  • et al.
International Journal of Endocrinology and Metabolic Disorders (2021) 7(1)
DOI: 10.16966/2380-548x.171
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Background/Objective: Methylcobalamin Nasal Spray (NasoB12®, Troikaa, India) has been recently developed to overcome the drawbacks of currently available therapeutic routes. This study was designed to compare pharmacokinetics, safety and tolerability of methylcobalamin nasal spray with intramuscular injection.

Cite

CITATION STYLE

APA

H, D., V, A., A, M., & KR, P. (2021). Novel Methylcobalamin Nasal Spray versus Intramuscular Injection: A Randomized, Crossover Comparative Bioavailability Study. International Journal of Endocrinology and Metabolic Disorders, 7(1). https://doi.org/10.16966/2380-548x.171

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free